Competition is increasing and markets are becoming saturated. In the Healthcare and Life Science sectors, developments such as the pandemic and ACA have largely reshaped the environment, creating new threats and opportunities.

Whether you're a large corporation or a fast-growing startup, it's crucial to stay on top of the market changes in real-time. Imagine being the first to uncover business-critical insights and leveraging them to inform your corporate strategy.

Join the live webcast and learn how you can modernize your approach, ditch manual processes, and stay ahead of the curve. Some of the key topics our panel of experts will aim to cover during this session include among others:

• Top Industry trends – The newly emerged and those further accelerated by the pandemic.
• New market access challenges – The post-pandemic, post-ACA era.
• Valuing your competitive set in the marketiplace
• The increasing need for data in decision-making
• Addressing the emergence of non-traditional competitors
• Increase in targeted therapeutics – Has it made the value/ drug benefit case more black and white?
• Drug value evaluation – How have Payor bodies internationally increased scrutiny as part of approval decisions?